首页 > 市场调查报告书 > 医疗设备

眼科设备隐形眼镜

市场调查报告书

商品编码

1289776

全球下一代隐形眼镜和视觉支架市场 - 2023-2030年

Global Next Generation Contact Lenses and Visual Prostheses Market - 2023-2030

出版日期: 2023年06月12日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球下一代隐形眼镜和视觉假体市场在2022年达到1.725亿美元，预计到2030年将见证有利可图的增长，达到6.08亿美元。在预测期内（2023-2030），全球下一代隐形眼镜和视觉修复器市场预计将呈现17.7%的复合年增长率。

下一代隐形眼镜比传统的隐形眼镜更先进，可以纠正更广泛的视力问题。下一代隐形眼镜和视觉义肢是在眼睛的天然晶状体被摘除或损坏后取代其功能的设备。它们可用于治疗白内障、青光眼和其他眼部疾病。

老年人口中视网膜疾病发病率的上升是下一代隐形眼镜和视觉修复器市场的主要驱动力之一。最普遍的视网膜疾病是AMD、高血压视网膜病变、视网膜外膜、BRVO和糖尿病视网膜病变。

市场动态

与眼睛有关的疾病的发病率不断上升

在全球范围内，特别是在印度，眼睛疾病的频率正在上升。例如，根据世界卫生组织（WHO）的数据，全世界至少有22亿人患有近视或远视。根据世界卫生组织的说法，如果病人得到适当的诊断和护理，至少有10亿例视力损伤可能会被避免。

由于紧张的生活方式，印度的视力下降病例正在上升。根据一项大规模的研究，其中包括14.5万名患者的数据，2019年干眼症的病例增加到21000例。报告指出，印度正处于干眼症流行的边缘。到2030年，它将影响约40%的城市人口。

眼科医生的短缺

尽管近年来，对眼科医生的需求急剧扩大。这在不发达国家尤为明显。例如，在印度，每90,000人就有一名眼科医生，但美国的比例是1：15。每百万人的平均眼科医生数量因经济发展而异，从低收入国家的每百万人9名到高收入国家的79名。

COVID-19影响分析

这场大流行阻碍了下一代隐形眼镜研究和开发的进展。封锁、社会疏远策略和受限的融资前景造成了实验室和研究设施的中断。这可能会推后将新的创新产品推向市场的时间尺度。

大流行病对全球供应链产生了重大影响，导致许多项目的生产和交付中断。这些中断有可能影响下一代隐形眼镜的制造和供应，包括材料、部件和制造设备的采购。

Market Overview

The Global Next Generation Contact Lenses And Visual Prostheses Market reached US$ 172.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 608.0 million by 2030. The global next generation contact lenses and visual prostheses market is expected to exhibit a CAGR of 17.7% during the forecast period (2023-2030).

Next-generation contact lenses are more advanced than traditional contact lenses and can correct a wider range of vision problems. next-generation contact lenses and visual prostheses are devices that replace the function of the eye's natural lens after it has been removed or damaged. They can be used to treat cataracts, glaucoma, and other eye conditions.

The rising prevalence of retinal diseases amongst the geriatric population is one of the major drivers for the next generation contact lenses & visual prostheses market. The most prevalent retinal diseases are AMD, hypertensive retinopathy, epiretinal membrane, BRVO, and diabetic retinopathy.

Market Dynamics

Rising Prevalence of Eye Related Diseases

The frequency of eye diseases is increasing globally, particularly in India. For instance, according to the World Health Organization (WHO), at least 2.2 billion people worldwide suffer from near- or far-sightedness. According to the World Health Organization, if the patient had received the proper diagnosis and care, at least one billion cases of vision impairment may have been avoided.

Due to a hectic lifestyle, cases of vision loss are on the rise in India. According to a large-scale study, which included data from 14.5 lakh patients, the number of cases of dry eye disease increased to 21,000 in 2019. It states that India is on the verge of a dry eye disease epidemic. By 2030, it will affect approximately 40% of the urban population.

Shortage of Ophthalmologists

Although the need for ophthalmologists has expanded dramatically in recent years. This is especially noticeable in underdeveloped nations. In India, for example, there is one ophthalmologist for every 90,000 people, but the US has a ratio of 1:15. The average number of ophthalmologists per million people varies according to economic development, ranging from 9 per million in low-income nations to 79 million in high-income countries.

COVID-19 Impact Analysis

The pandemic has hampered the advancement of next-generation contact lens research and development. Lockdowns, social distancing tactics, and restricted financing prospects have caused disruptions in laboratories and research facilities. This might possibly push back the timescale for bringing new innovations to market.

The pandemic has had a substantial impact on the global supply chain, causing interruptions in the manufacture and delivery of many items. These disruptions have the potential to influence the manufacture and availability of next-generation contact lenses, including the procurement of materials, components, and manufacturing equipment.

Segment Analysis

The global next generation contact lenses and visual prostheses market is segmented based on type of product , type of diseases and end user .

The Contact Lens Segment will be Dominated by Market Players During the Forecast Period

Contact lens is expected to be the dominating segment with the percentage around 81.3% in the forecast period as a result of product launches and approvals. For instance, Alcon Canada, for example, introduced new total toric lenses for astigmatic patients. Alcon, a worldwide pioneer in eye care devoted to helping people see brilliantly, announced the Canadian debut of a total of 30 for Astigmatism and Dailies Total 1 Astigmatism.

Alcon's line of reusable and daily disposable lenses has been expanded with high-performing solutions targeted at astigmatic patients. According to estimates, toric lenses (for astigmatic correction) are the fastest expanding section of the contact lens industry, providing an opportunity for eye care specialists to deliver excellent vision correction and patient care.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America dominates the market for next-generation contact lenses and visual prostheses accounting for 42.1% and this trend is expected to continue during the projected period. The region's dominance is likely to continue during the projection period, owing to factors such as rising diabetes incidence, high disposable income, and growing awareness of modern technology for the treatment of eyesight impairment.

Due to factors such as improved healthcare infrastructure and the availability of innovative medicines for treating blindness, as well as economic expansion in countries such as India and China, the Asia Pacific area is expected to be the fastest-growing regional sector throughout the projection period.

Competitive Landscape

The major global players include: Johnson & Johnson, NIDEK, Novartis, Second Sight, NJ Retina, Interojo, OcuMedic, Bausch & Lomb, Pixium Vision, Menicon, and others.

Why Purchase the Report?
To visualize the global next generation contact lenses and visual prostheses market segmentation based on the type of product, type of diseases, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global next generation contact lenses and visual prostheses market level with all segments.
Pdf report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global next generation contact lenses and visual prostheses market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by type of product
3.2. Snippet by type of diseases

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rising prevalence of retinal diseases amongst the geriatric population
- 4.1.2. Restraints
  - 4.1.2.1. Shortage of Expert ophthalmologists
- 4.1.3. Opportunity
  - 4.1.3.1. Increasing product launches and approvals
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Type of Product

7.1 Contact lens
7.2 Visual Prostheses

8. By Type of Diseases

8.1. Glaucoma
8.2. Diabetes
8.3. AMD
8.4. Retinitis Pigmentosa
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. The U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. The UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country